Katie A Lloyd

I am currently a postdoctoral researcher in Translational Medicine at the University of Liverpool. I undertook my undergraduate studies at the University of Liverpool, graduating with a first-class honours degree in 2012 then completed my PhD under the supervision of Professors Mark Pritchard and Andrea Varro, where I investigated the role of microRNAs in the pathogenesis of type 1 gastric neuroendocrine tumours.

During my postdoctoral career, I worked first for my PhD supervisor Professor Pritchard, on an industry funded project investigating the bioavailability and efficacy of a novel gastrin inhibitor, before working under the leadership of Professor Chris Probert, funded by the EC FP7 SysmedIBD project. This project established a consortium of clinician scientists, biological scientists, and mathematicians to apply systems medicines approaches to better understand inflammatory bowel diseases.

Following the completion of the SysmedIBD project in November 2017, I have been employed as the MRC MECNUT postdoc, investigating the roles of permitted emulsifiers in the risk of developing inflammatory bowel disease and metabolic syndrome.